25 May, 2023“The availability of oncology drugs needs to improve, as only 57% of those approved in Europe are available”The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]
ES
EN